Early Compensatory Mechanisms in LRRK2 Mutation Carriers

Mov Disord. 2022 Mar;37(3):662-663. doi: 10.1002/mds.28908. Epub 2022 Jan 10.

Authors

Giovanni Palermo¹, Daniela Frosini¹, Angelo Antonini², Roberto Ceravolo¹

Affiliations

¹ Department of Clinical and Experimental Medicine, Center for Neurodegenerative Diseases-Parkinson's Disease and Movement Disorders, University of Pisa, Pisa, Italy.
² Department of Neuroscience, Parkinson and Movement Disorders Unit, Center for Neurodegenerative Diseases CESNE, University of Padova, Padova, Italy.

PMID: 35005801
DOI: 10.1002/mds.28908

No abstract available

Publication types

Letter
Comment

MeSH terms

Heterozygote
Humans
Leucine-Rich Repeat Serine-Threonine Protein Kinase-2* / genetics
Mutation / genetics

Substances

LRRK2 protein, human
Leucine-Rich Repeat Serine-Threonine Protein Kinase-2